HomeSite MapContact Us


Selecta Russia

Для того, чтобы увидеть эту страницу на русском языке, нажмите здесь

Click here for Russian

Selecta Russia's mission is to build a robust clinical pipeline of immunology related therapies consisting of Selecta's proprietary Synthetic Vaccine Particles (SVP™) technology and clinical stage compounds in-licensed from biotech and pharmaceutical companies. Our activities in Russia support Selecta Biosciences' goals of expanding its portfolio of immunotherapies and accelerating its clinical development, while recognizing the specific requirements of Russian patients. Selecta Russia R&D programs are developed in close coordination with Selecta in Boston.

© 2016 Selecta Biosciences, Inc.  |  480 Arsenal St., Building One, Watertown, MA 02472  |  Phone: 617-923-1400  |   Fax: 617-924-3454  |  Email:
Privacy Policy  |  Web site designed and developed by RainCastle Communications, Inc.